ABBOTT LABORATORIES (ABT) Fundamental Analysis & Valuation

NYSE:ABT • US0028241000

Current stock price

95.47 USD
-6.09 (-6%)
At close:
96.06 USD
+0.59 (+0.62%)
Pre-Market:

This ABT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. ABT Profitability Analysis

1.1 Basic Checks

  • In the past year ABT was profitable.
  • In the past year ABT had a positive cash flow from operations.
  • ABT had positive earnings in each of the past 5 years.
  • ABT had a positive operating cash flow in each of the past 5 years.
ABT Yearly Net Income VS EBIT VS OCF VS FCFABT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • ABT's Return On Assets of 7.52% is amongst the best of the industry. ABT outperforms 87.23% of its industry peers.
  • ABT has a Return On Equity of 12.51%. This is amongst the best in the industry. ABT outperforms 87.77% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 9.14%, ABT belongs to the top of the industry, outperforming 87.77% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for ABT is in line with the industry average of 9.15%.
  • The 3 year average ROIC (8.63%) for ABT is below the current ROIC(9.14%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROIC 9.14%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ABT Yearly ROA, ROE, ROICABT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • ABT has a Profit Margin of 14.72%. This is amongst the best in the industry. ABT outperforms 90.43% of its industry peers.
  • In the last couple of years the Profit Margin of ABT has grown nicely.
  • ABT has a Operating Margin of 18.78%. This is amongst the best in the industry. ABT outperforms 90.43% of its industry peers.
  • In the last couple of years the Operating Margin of ABT has grown nicely.
  • ABT has a Gross Margin of 56.66%. This is comparable to the rest of the industry: ABT outperforms 56.91% of its industry peers.
  • ABT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.78%
PM (TTM) 14.72%
GM 56.66%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
ABT Yearly Profit, Operating, Gross MarginsABT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. ABT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ABT is creating some value.
  • The number of shares outstanding for ABT has been increased compared to 1 year ago.
  • The number of shares outstanding for ABT has been reduced compared to 5 years ago.
  • The debt/assets ratio for ABT has been reduced compared to a year ago.
ABT Yearly Shares OutstandingABT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
ABT Yearly Total Debt VS Total AssetsABT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

  • ABT has an Altman-Z score of 4.64. This indicates that ABT is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.64, ABT is in the better half of the industry, outperforming 73.94% of the companies in the same industry.
  • The Debt to FCF ratio of ABT is 1.75, which is an excellent value as it means it would take ABT, only 1.75 years of fcf income to pay off all of its debts.
  • ABT has a better Debt to FCF ratio (1.75) than 86.70% of its industry peers.
  • A Debt/Equity ratio of 0.19 indicates that ABT is not too dependend on debt financing.
  • ABT has a Debt to Equity ratio of 0.19. This is comparable to the rest of the industry: ABT outperforms 57.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Altman-Z 4.64
ROIC/WACC1.08
WACC8.49%
ABT Yearly LT Debt VS Equity VS FCFABT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 1.58 indicates that ABT should not have too much problems paying its short term obligations.
  • ABT's Current ratio of 1.58 is on the low side compared to the rest of the industry. ABT is outperformed by 75.53% of its industry peers.
  • A Quick Ratio of 1.18 indicates that ABT should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.18, ABT is not doing good in the industry: 73.40% of the companies in the same industry are doing better.
  • The current and quick ratio evaluation for ABT is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.18
ABT Yearly Current Assets VS Current LiabilitesABT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ABT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 9.00% over the past year.
  • The Earnings Per Share has been growing slightly by 7.13% on average over the past years.
  • ABT shows a small growth in Revenue. In the last year, the Revenue has grown by 6.59%.
  • Measured over the past years, ABT shows a small growth in Revenue. The Revenue has been growing by 5.08% on average per year.
EPS 1Y (TTM)9%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%5.5%
Revenue 1Y (TTM)6.59%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%7.78%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.38% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 7.06% on average over the next years.
EPS Next Y10.72%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue Next Year8.79%
Revenue Next 2Y8.44%
Revenue Next 3Y7.93%
Revenue Next 5Y7.06%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ABT Yearly Revenue VS EstimatesABT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
ABT Yearly EPS VS EstimatesABT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. ABT Valuation Analysis

4.1 Price/Earnings Ratio

  • ABT is valuated rather expensively with a Price/Earnings ratio of 18.32.
  • Compared to the rest of the industry, the Price/Earnings ratio of ABT indicates a rather cheap valuation: ABT is cheaper than 80.85% of the companies listed in the same industry.
  • ABT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.53.
  • ABT is valuated correctly with a Price/Forward Earnings ratio of 15.19.
  • 87.77% of the companies in the same industry are more expensive than ABT, based on the Price/Forward Earnings ratio.
  • ABT is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.95, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.32
Fwd PE 15.19
ABT Price Earnings VS Forward Price EarningsABT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 79.26% of the companies in the same industry are more expensive than ABT, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABT indicates a rather cheap valuation: ABT is cheaper than 86.17% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.43
EV/EBITDA 14.81
ABT Per share dataABT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • ABT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of ABT may justify a higher PE ratio.
PEG (NY)1.71
PEG (5Y)2.57
EPS Next 2Y10.46%
EPS Next 3Y10.33%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. ABT Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.64%, ABT has a reasonable but not impressive dividend return.
  • The stock price of ABT dropped by -21.59% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 0.24, ABT pays a better dividend. On top of this ABT pays more dividend than 96.81% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, ABT pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.64%

5.2 History

  • On average, the dividend of ABT grows each year by 10.37%, which is quite nice.
  • ABT has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ABT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.37%
Div Incr Years34
Div Non Decr Years34
ABT Yearly Dividends per shareABT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 63.09% of the earnings are spent on dividend by ABT. This is not a sustainable payout ratio.
  • ABT's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP63.09%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
ABT Yearly Income VS Free CF VS DividendABT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
ABT Dividend Payout.ABT Dividend Payout, showing the Payout Ratio.ABT Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ABT Fundamentals: All Metrics, Ratios and Statistics

ABBOTT LABORATORIES

NYSE:ABT (4/16/2026, 8:12:08 PM)

Premarket: 96.06 +0.59 (+0.62%)

95.47

-6.09 (-6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-16
Earnings (Next)N/A
Inst Owners81.92%
Inst Owner Change-0.1%
Ins Owners0.47%
Ins Owner Change1.19%
Market Cap165.90B
Revenue(TTM)45.13B
Net Income(TTM)6.52B
Analysts80.57
Price Target134.69 (41.08%)
Short Float %1.38%
Short Ratio2.17
Dividend
Industry RankSector Rank
Dividend Yield 2.64%
Yearly Dividend2.37
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years34
Div Non Decr Years34
Ex-Date04-15
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)-0.37%
PT rev (3m)-7.69%
EPS NQ rev (1m)-0.17%
EPS NQ rev (3m)-4.49%
EPS NY rev (1m)-0.73%
EPS NY rev (3m)-0.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)1.08%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 18.32
Fwd PE 15.19
P/S 3.74
P/FCF 22.43
P/OCF 17.34
P/B 3.18
P/tB 7.35
EV/EBITDA 14.81
EPS(TTM)5.21
EY5.46%
EPS(NY)6.28
Fwd EY6.58%
FCF(TTM)4.26
FCFY4.46%
OCF(TTM)5.51
OCFY5.77%
SpS25.51
BVpS30
TBVpS12.99
PEG (NY)1.71
PEG (5Y)2.57
Graham Number59.3021 (-37.88%)
Profitability
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROCE 11.86%
ROIC 9.14%
ROICexc 10.47%
ROICexgc 20.23%
OM 18.78%
PM (TTM) 14.72%
GM 56.66%
FCFM 16.68%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Debt/EBITDA 0.86
Cap/Depr 69.67%
Cap/Sales 4.9%
Interest Coverage 15.28
Cash Conversion 83.6%
Profit Quality 113.35%
Current Ratio 1.58
Quick Ratio 1.18
Altman-Z 4.64
F-Score6
WACC8.49%
ROIC/WACC1.08
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)9%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%5.5%
EPS Next Y10.72%
EPS Next 2Y10.46%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue 1Y (TTM)6.59%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%7.78%
Revenue Next Year8.79%
Revenue Next 2Y8.44%
Revenue Next 3Y7.93%
Revenue Next 5Y7.06%
EBIT growth 1Y18.35%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year26.44%
EBIT Next 3Y14.4%
EBIT Next 5Y13.17%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%

ABBOTT LABORATORIES / ABT Fundamental Analysis FAQ

What is the fundamental rating for ABT stock?

ChartMill assigns a fundamental rating of 7 / 10 to ABT.


What is the valuation status for ABT stock?

ChartMill assigns a valuation rating of 6 / 10 to ABBOTT LABORATORIES (ABT). This can be considered as Fairly Valued.


How profitable is ABBOTT LABORATORIES (ABT) stock?

ABBOTT LABORATORIES (ABT) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for ABT stock?

The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABT) is 18.32 and the Price/Book (PB) ratio is 3.18.


How sustainable is the dividend of ABBOTT LABORATORIES (ABT) stock?

The dividend rating of ABBOTT LABORATORIES (ABT) is 7 / 10 and the dividend payout ratio is 63.09%.